Synapse

← Oncology and Translational Medicine

Papers in Oncology and Translational Medicine

Page 2 · newest first

  1. Pan-cancer analysis of the role of ARHGDIB in human cancersOncology and Translational Medicine · 2025
  2. Multiple liver metastases caused by micro-pancreatic primary VIPoma: A case report and literature reviewOncology and Translational Medicine · 2025
  3. Integrative human pan-cancer analysis of NDC80Oncology and Translational Medicine · 2025
  4. Research status of colorectal cancer treatment based on natural killer cell immunotherapyOncology and Translational Medicine · 2025
  5. The sex-based profiles of molecular biomarkers for immunotherapy responses of cancer patientsOncology and Translational Medicine · 2025
  6. Exceptional and durable response with pembrolizumab in a patient with microsatellite stable metastatic castrate-resistant prostate cancer: High tumor mutational burden and circulating tumor DNA clearance as predictive biomarkersOncology and Translational Medicine · 2025
  7. Interventional management of pancreatic cancer: Current strategies and future horizonsOncology and Translational Medicine · 2025
  8. Novel perspectives on combining immune checkpoint inhibitors and antiangiogenic drugs for advanced hepatocellular carcinomaOncology and Translational Medicine · 2025
  9. Prognostic models for lung cancer in smokers and nonsmokers: an updated systematic review and meta-analysisOncology and Translational Medicine · 2025
  10. Characteristics of intracranial sclerosing epithelioid fibrosarcoma and review of related literatureOncology and Translational Medicine · 2025
  11. Systemic immune-inflammation index as a prognostic indicator in patients with advanced non–small cell lung cancer receiving first-line chemotherapy combined with immunotherapyOncology and Translational Medicine · 2025
  12. Zinc dyshomeostasis: an emerging hallmark of cancerOncology and Translational Medicine · 2025
  13. Liver resection for hepatocellular carcinoma with vascular invasion: Current insights and future perspectivesOncology and Translational Medicine · 2025
  14. Comprehensive insights into systemic therapy for the whole-course management of hepatocellular carcinomaOncology and Translational Medicine · 2025
  15. Crosstalk between colorectal tumor metabolism and immune cells in the tumor microenvironmentOncology and Translational Medicine · 2025
  16. Pentose-phosphate pathway reveals complex tumor-promoting features, immunity characteristics, and drug response in human cancersOncology and Translational Medicine · 2025
  17. Impact of hormone receptor and HER2 conversions on survival after neoadjuvant chemotherapy in breast cancer patientsOncology and Translational Medicine · 2025
  18. Irreversible electroporation: current research status and controversiesOncology and Translational Medicine · 2025
  19. Berberine restrained proliferation, invasion, and migration by targeting the glycogen synthase kinase 3β/β-catenin pathway in lung adenocarcinoma cellsOncology and Translational Medicine · 2025
  20. Prevalence and genotype distribution of human papillomavirus among women with cervical or vaginal lesions in Jiangsu, China: 2 cross-sectional studies (2012–2013 and 2020–2021)Oncology and Translational Medicine · 2025
  21. Identification of target gene–microribonucleic acid–transcription factor regulatory networks in colorectal adenoma-carcinoma sequenceOncology and Translational Medicine · 2025
  22. Advances in immunotherapy and targeted therapy for pancreatic cancerOncology and Translational Medicine · 2024
  23. Advances in basic and translational research into nasopharyngeal carcinomaOncology and Translational Medicine · 2024
  24. Pan-cancer transcriptomic analysis reveals HSPB8 as a prognostic and immunological biomarker in colorectal cancerOncology and Translational Medicine · 2024
  25. Advancements in conventional cancer therapy combined with immunotherapyOncology and Translational Medicine · 2024
  26. Perspectives on the potential application of microRNAs in the diagnosis and treatment of triple-negative breast cancerOncology and Translational Medicine · 2024
  27. Association of eczema with risk of pan-cancers: a two-sample Mendelian randomization studyOncology and Translational Medicine · 2024
  28. Exploring combination therapy centered on targeted immunotherapy for advanced hepatocellular carcinoma: a beacon of hopeOncology and Translational Medicine · 2024
  29. MiR-340-5p affects the proliferation and transfer of gastric cancer cells by targeting lncRNA HCG11 and NRF2 expressionOncology and Translational Medicine · 2024
  30. Bioinformatics analysis of the association between miR-942-5p–induced downregulation of PIEZO-type mechanosensitive ion channel component 1 and poor prognosis in non–small cell lung cancer mediated by the mitogen-activated protein kinase pathway signaling pathwayOncology and Translational Medicine · 2024
  31. Remodeling tumor-associated macrophages in the tumor microenvironmentOncology and Translational Medicine · 2024
  32. Development of organ transplantation in China and organ donationOncology and Translational Medicine · 2024
  33. DDHD2 is involved in the malignant progression of early luminal A breast cancer by changing cell membrane proteins and immune responses functionalityOncology and Translational Medicine · 2024
  34. Advances in treatment strategies for non–clear cell renal cell carcinomaOncology and Translational Medicine · 2024
  35. Transformation of lung adenocarcinoma into small cell lung cancer after treatment with epidermal growth factor receptor tyrosine kinase inhibitorsOncology and Translational Medicine · 2024
  36. Noncausal relationship between body weight and breast cancer based on bidirectional Mendelian randomization evidenceOncology and Translational Medicine · 2024
  37. Sex bias in FGFR3 somatic mutations in bladder cancerOncology and Translational Medicine · 2024
  38. Optical molecular imaging in cancer research: current impact and future prospectOncology and Translational Medicine · 2024
  39. Evaluating the diagnostic accuracy of microRNA-494 as a biomarker in cancers: A systematic review and meta-analysisOncology and Translational Medicine · 2024
  40. Advances in the therapeutic study of oncolytic virus in colorectal cancerOncology and Translational Medicine · 2024
  41. Studies on surgical methods for sporadic micromedullary thyroid carcinomaOncology and Translational Medicine · 2024
  42. Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinomaOncology and Translational Medicine · 2024
  43. MiR-450b-5p enhances the radiosensitivity of HR+ and HER2− breast cancer by targeting CDK6Oncology and Translational Medicine · 2024
  44. Exploring the connection between BRCA2 and thyroid cancerOncology and Translational Medicine · 2024
  45. Nanomaterials for refining tumor microenvironment and enhancing therapy in head and neck squamous cell carcinoma: a reviewOncology and Translational Medicine · 2024
  46. Efficacy evaluation and survival analysis of the combination of oxaliplatin plus Teysuno (SOX) with immune checkpoint inhibitors in the conversion therapy of locally advanced gastric cancerOncology and Translational Medicine · 2024
  47. Progress and current perspectives of diagnosis and treatment of hepatoid adenocarcinoma of the stomachOncology and Translational Medicine · 2024
  48. Massive bleeding in small intestinal mucosa-associated lymphoid tissue lymphoma associated with COVID-19 infection: a case reportOncology and Translational Medicine · 2024
  49. TROVE2 regulated invasion and migration of hepatocellular carcinoma cells via heparanaseOncology and Translational Medicine · 2024
  50. BMI1 overexpression is correlated with a poor prognosis and immune infiltration in hepatocellular carcinomaOncology and Translational Medicine · 2024